
Treatment with zoledronate subsequent to denosumab in osteoporosis: a 2‐year randomized study
The study included 61 postmenopausal women and men above 50 years discontinuing denosumab after 4.6±1.6 years. After 12 months, lumbar spine BMD decre...
The study included 61 postmenopausal women and men above 50 years discontinuing denosumab after 4.6±1.6 years. After 12 months, lumbar spine BMD decre...